FATIMA DOUGLAS: Open Payments
NPI 1821799594 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 20 payments from 8 companies in 2025. Trend: 2023 $635 · 2024 $701 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $165 |
| MIMEDX Group, Inc. | 1 | $91 |
| Inspire Medical Systems, Inc. | 3 | $79 |
| Axsome Therapeutics, Inc. | 1 | $69 |
| Actelion Pharmaceuticals US, Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| PFIZER INC. | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $16 |
Products named: VERQUVO, INSPIRE, Auvelity, OPSUMIT, LEQVIO, WINREVAIR, ELIQUIS, ENTRESTO.
Industry payments across TX — which companies pay providers there.
